In the GEO dataset, BRAF V600E-mutant CRC patients exhibited significantly higher T cell exhaustion scores, T cell regulation scores, and immune checkpoint blockade (ICB) resistance scores compared to wild-type CRC patients. This evidence concerns the gene BRAF and colorectal carcinoma.